A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : GEM

Search Conditions:
Search Keyword : GEM
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 2 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: GEM
Appearance Frequency: 2102 time(s)
Long forms: 181

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
gemcitabine
(1165 times)
Neoplasms
(639 times)
OS (98 times)
5-FU (75 times)
NSCLC (74 times)
1994 Weekly gemcitabine in advanced or metastatic solid tumors. A clinical phase I study.
genetically engineered mouse
(148 times)
Neoplasms
(57 times)
NF1 (10 times)
PDAC (9 times)
PCa (4 times)
2000 The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting.
gaseous elemental mercury
(86 times)
Environmental Health
(76 times)
RGM (17 times)
GOM (16 times)
PBM (11 times)
2003 Springtime depletion of mercury in the European Arctic as observed at Svalbard.
glycolipid-enriched membrane
(59 times)
Biochemistry
(23 times)
cld7 (3 times)
GPI (3 times)
TJ (3 times)
1996 Exclusion of CD45 inhibits activity of p56lck associated with glycolipid-enriched membrane domains.
gemfibrozil
(58 times)
Toxicology
(19 times)
CBZ (5 times)
PP (4 times)
PPARalpha (4 times)
1989 Quantitative assessment of enzyme induction by peroxisome proliferators and application to determination of effects on triglyceride biosynthesis in primary cultures of rat hepatocytes.
geriatric evaluation and management
(52 times)
Geriatrics
(37 times)
CI (5 times)
ADL (4 times)
UPC (4 times)
1991 Impacts of geriatric evaluation and management programs on defined outcomes: overview of the evidence.
Gram-positive enhancer matrix
(36 times)
Microbiology
(9 times)
PA (8 times)
LAB (3 times)
LysM (2 times)
2006 Novel surface display system for proteins on non-genetically modified gram-positive bacteria.
genetically engineered microorganism
(31 times)
Environmental Health
(17 times)
MBR (4 times)
CAS (3 times)
HRT (2 times)
1991 Monitoring survival and gene transfer in soil microcosms of recombinant Escherichia coli designed to represent an industrial production strain.
Genes in Myopia
(23 times)
Ophthalmology
(12 times)
ATR (6 times)
DZ (4 times)
MZ (4 times)
2005 Methodology and recruitment of probands and their families for the Genes in Myopia (GEM) Study.
10  gemcitabine hydrochloride
(22 times)
Neoplasms
(10 times)
PLGA (2 times)
5-FU (1 time)
BCa (1 time)
2004 Surgical resection deteriorates gemcitabine-induced leukopenia in pancreatic cancer.
11  genome-scale metabolic model
(20 times)
Biotechnology
(7 times)
ADI (1 time)
Arg (1 time)
AT (1 time)
2014 A model-driven quantitative metabolomics analysis of aerobic and anaerobic metabolism in E. coli K-12 MG1655 that is biochemically and thermodynamically consistent.
12  gaseous elemental Hg
(18 times)
Environmental Health
(17 times)
MDF (2 times)
TGM (2 times)
CFPP (1 time)
2004 Speciation and mass-balance of mercury from pulverized coal fired power plants burning western Canadian subbituminous coals.
13  Guideline Elements Model
(16 times)
Medical Informatics
(16 times)
CPG (2 times)
CPGs (2 times)
AICG (1 time)
2000 GEM: a proposal for a more comprehensive guideline document model using XML.
14  gas electron multiplier
(14 times)
Nuclear Medicine
(8 times)
TEPC (5 times)
EAST (1 time)
PHS (1 time)
2004 First microdosimetric measurements with a TEPC based on a GEM.
15  Genes, Environment, and Melanoma
(14 times)
Neoplasms
(6 times)
AJCC (3 times)
CI (2 times)
HR (2 times)
2012 Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas.
16  Ginkgo Evaluation of Memory
(12 times)
Geriatrics
(4 times)
CI (3 times)
CDR (2 times)
HR (2 times)
2006 The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia.
17  goal equivalent manifold
(10 times)
Physiology
(5 times)
CNSLBP (1 time)
COM (1 time)
EMG (1 time)
2006 Body-goal variability mapping in an aiming task.
18  gemcitabine monotherapy
(9 times)
Neoplasms
(5 times)
ORR (2 times)
OS (2 times)
Pca (2 times)
2004 Irinotecan plus gemcitabine results in no survival advantage compared with gemcitabine monotherapy in patients with locally advanced or metastatic pancreatic cancer despite increased tumor response rate.
19  Gaussian electrostatic model
(8 times)
Chemistry
(5 times)
QM/MM (2 times)
EDA (1 time)
FFP (1 time)
2006 Quantum mechanics/molecular mechanics electrostatic embedding with continuous and discrete functions.
20  Gender Empowerment Measure
(8 times)
Public Health
(2 times)
GDP (3 times)
CI (2 times)
GDI (2 times)
2004 Gender and culture differences in emotion.
21  gene expression model
(8 times)
Neoplasms
(2 times)
CDS (1 time)
GE (1 time)
GES (1 time)
2008 Analyzing M-CSF dependent monocyte/macrophage differentiation: expression modes and meta-modes derived from an independent component analysis.
22  general emergency medicine
(8 times)
Pediatrics
(7 times)
PEM (7 times)
ED (4 times)
CI (2 times)
1997 Factors influencing termination of resuscitative efforts in children: a comparison of pediatric emergency medicine and adult emergency medicine physicians.
23  Graduate Entry Medicine
(8 times)
Education
(4 times)
CAP (1 time)
CI (1 time)
DEM (1 time)
2007 Graduate entry medicine: high aspirations at birth.
24  Gender Equitable Men
(7 times)
Public Health
(4 times)
SRPS (2 times)
AOR (1 time)
CHARM (1 time)
2006 Challenging and changing gender attitudes among young men in Mumbai, India.
25  gemifloxacin
(6 times)
Anti-Bacterial Agents
(2 times)
CIP (3 times)
GAT (3 times)
LEV (2 times)
2000 Gemifloxacin and ciprofloxacin pharmacodynamics in an in-vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and doses.
26  gemcitabine alone
(5 times)
Neoplasms
(3 times)
ABC-02 (1 time)
BTC (1 time)
CI (1 time)
2002 Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma.
27  gene expression microarray
(5 times)
Neoplasms
(4 times)
BLBC (1 time)
CUP (1 time)
DEGs (1 time)
2004 Predicting biomarkers for ovarian cancer using gene-expression microarrays.
28  generalized expectation maximization
(5 times)
Medical Informatics
(2 times)
BWT (1 time)
GSM (1 time)
LRMF (1 time)
1989 A generalized EM algorithm for 3-D Bayesian reconstruction from Poisson data using Gibbs priors.
29  genome-scale metabolic network model
(5 times)
Microbiological Phenomena
(1 time)
Tn-seq (1 time)
TSAS (1 time)
2015 Applications of genome-scale metabolic network model in metabolic engineering.
30  Germline-encoded mycolyl lipid-reactive
(5 times)
Allergy and Immunology
(3 times)
TCRs (3 times)
GMM (1 time)
MAIT (1 time)
2013 A conserved human T cell population targets mycobacterial antigens presented by CD1b.
31  Germplasm Enhancement of Maize
(5 times)
Botany
(2 times)
CA (1 time)
CMLs (1 time)
COMT (1 time)
2012 Genetic characterization of a core set of a tropical maize race Tuxpeno for further use in maize improvement.
32  Gestational Diabetes' Effects on Moms
(5 times)
Endocrinology
(2 times)
GDM (2 times)
CI (1 time)
DPP (1 time)
2014 A pragmatic cluster randomized clinical trial of diabetes prevention strategies for women with gestational diabetes: design and rationale of the Gestational Diabetes' Effects on Moms (GEM) study.
33  GreenFeed emission monitoring
(5 times)
Veterinary Medicine
(3 times)
DMP (2 times)
MY (2 times)
RC (2 times)
2015 Estimating daily methane production in individual cattle with irregular feed intake patterns from short-term methane emission measurements.
34  Growth and Empowerment Measure
(5 times)
Public Health
(2 times)
FWB (1 time)
2010 Psychometric validation of the Growth and Empowerment Measure (GEM) applied with Indigenous Australians.
35  gel extrusion module
(4 times)
Pharmacology
(3 times)
DMA (1 time)
SHS-GC (1 time)
2002 Static headspace gas chromatographic analysis of the residual solvents in gel extrusion module tablet formulations.
36  Genetically Engineered Mice
(4 times)
Pathology
(2 times)
MMTV (1 time)
mPIN (1 time)
2001 Validity of mouse mammary tumour models for human breast cancer: comparative pathology.
37  GEnomic Multi-tool
(4 times)
Clinical Laboratory Techniques
(2 times)
--- 2012 Fast computation and applications of genome mappability.
38  Global Evidence Mapping
(4 times)
Medicine
(2 times)
TBI (3 times)
ERABI (2 times)
SCI (2 times)
2011 The Global Evidence Mapping Initiative: scoping research in broad topic areas.
39  Grid-Enabled Measures
(4 times)
Medical Informatics
(1 time)
NCI (3 times)
caDSR (2 times)
CDE (1 time)
2011 Grid-enabled measures: using Science 2.0 to standardize measures and share data.
40  group epitope mapping
(4 times)
Molecular Biology
(2 times)
STD (3 times)
CAPs (1 time)
GEM-CRL (1 time)
2001 Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor.
41  GTP binding protein overexpressed in skeletal muscle
(4 times)
Pathology
(1 time)
CXCR7 (1 time)
HCC (1 time)
IMF (1 time)
2010 A systemic network for Chlamydia pneumoniae entry into human cells.
42  Generalized Evaporation Model
(3 times)
Nuclear Medicine
(2 times)
JQMD (2 times)
PHITS (2 times)
QMD (1 time)
2005 Simulations of an accelerator-based shielding experiment using the particle and heavy-ion transport code system PHITS.
43  genome-scale model
(3 times)
Biotechnology
(3 times)
FBA (1 time)
Mtb (1 time)
TB (1 time)
2013 Basic and applied uses of genome-scale metabolic network reconstructions of Escherichia coli.
44  Genome-scale models of metabolism
(3 times)
Biotechnology
(2 times)
FBA (2 times)
ACT (1 time)
eMOMA (1 time)
2016 Transcriptomics-based strain optimization tool for designing secondary metabolite overproducing strains of Streptomyces coelicolor.
45  geriatric emergency management
(3 times)
Emergency Medicine
(2 times)
ED (1 time)
GDH (1 time)
SGS (1 time)
2008 EDs are using 'GEMs' to improve elder care.
46  global energy minimum
(3 times)
Chemistry
(1 time)
eff (1 time)
GA (1 time)
HA (1 time)
1996 New theoretical methodology for elucidating the solution structure of peptides from NMR data. II. Free energy of dominant microstates of Leu-enkephalin and population-weighted average nuclear Overhauser effects intensities.
47  Goals for Eating and Moving
(3 times)
Clinical Trials as Topic
(1 time)
EUC (2 times)
PCMH (1 time)
VA (1 time)
2018 Development of a 5As-based technology-assisted weight management intervention for veterans in primary care.
48  gradient echo memory
(3 times)
Biology
(1 time)
QKD (1 time)
2008 Multimodal properties and dynamics of gradient echo quantum memory.
49  gas exchange monitor
(2 times)
Nutritional Sciences
(1 time)
ETT (1 time)
PIP (1 time)
VENT (1 time)
1988 Measuring infant metabolism: design and testing of a miniature gas exchange monitor.
50  Gaussian mixture-model with expectation maximization
(2 times)
Eye Diseases
(1 time)
CL (1 time)
FDT (1 time)
LR (1 time)
2014 Recognizing patterns of visual field loss using unsupervised machine learning.
51  Gel Bead in Emulsion
(2 times)
Biology
(1 time)
REXTAL (2 times)
2018 REXTAL: Regional Extension of Assemblies Using Linked-Reads.
52  gel-based emulsions
(2 times)
Chemistry
(2 times)
CsA (1 time)
SMEDDS (1 time)
2005 Novel gels and their dispersions--oral drug delivery systems for ciclosporin.
53  gemcitabine group
(2 times)
Neoplasms
(2 times)
LAPC (1 time)
2008 Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study.
54  gemcitabine triphosphate, dFdCTP
(2 times)
Nanotechnology
(1 time)
dFdU (2 times)
EPR (1 time)
HSA (1 time)
2017 Dual Enzymatic Reaction-Assisted Gemcitabine Delivery Systems for Programmed Pancreatic Cancer Therapy.
55  gemifloxacin mesylate
(2 times)
Physiology
(1 time)
LIN (1 time)
2014 Spectrofluorimetric determination of gemifloxacin mesylate and linezolid in pharmaceutical formulations: Application of quinone-based fluorophores and enhanced native fluorescence.
56  GEM + ZA-treated mice was significantly decreased compared to the control group
(2 times)
General Surgery
(1 time)
PDOX (1 time)
ZA (1 time)
2015 Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer.
57  Genders extended model
(2 times)
Cardiology
(2 times)
AUC (2 times)
CAD (2 times)
IDI (2 times)
2017 Validation and comparison of four models to calculate pretest probability of obstructive coronary artery disease in a Chinese population: A coronary computed tomographic angiography study.
58  gene expression modulation
(2 times)
Biochemistry
(2 times)
--- 2010 Discovering modulators of gene expression.
59  Gene, Environment and Methylation
(2 times)
Medical Informatics
(1 time)
EWAS (1 time)
methQTL (1 time)
2016 Gene, Environment and Methylation (GEM): a tool suite to efficiently navigate large scale epigenome wide association studies and integrate genotype and interaction between genotype and environment.
60  general effective media
(2 times)
Biophysics
(1 time)
YSZ (1 time)
2018 Applying the general effective media (GEM) approach for analyzing the thermal conductivity of ZrO2-8YSZ composites.
61  generalized elastic model
(2 times)
Biophysics
(2 times)
FLE (1 time)
2010 Correlations in a generalized elastic model: fractional Langevin equation approach.
62  generalized EM
(2 times)
Statistics as Topic
(1 time)
EM (1 time)
HMMs (1 time)
IOHMM (1 time)
1996 Input-output HMMs for sequence processing.
63  generalized empirical method
(2 times)
Ethics
(1 time)
--- 2015 Palliative sedation, foregoing life-sustaining treatment, and aid-in-dying: what is the difference?
64  generalized Euler method
(2 times)
Biophysical Phenomena
(1 time)
MSGDTM (1 time)
2012 Fractional modeling dynamics of HIV and CD4+ T-cells during primary infection.
65  Genetic Evaluation of Men
(2 times)
Urology
(2 times)
GC (2 times)
GT (2 times)
PCa (2 times)
2018 Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling.
66  genetically modified mouse
(2 times)
Urologic Diseases
(1 time)
MM (1 time)
MPM (1 time)
PDX (1 time)
2012 Preclinical Remodeling of Human Prostate Cancer through the PTEN/AKT Pathway.
67  geometrically enhanced mixing
(2 times)
Biochemistry
(1 time)
CTCs (2 times)
PD (1 time)
2014 Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.
68  geriatric emergency medicine
(2 times)
Emergency Medicine
(2 times)
ED (2 times)
EM (1 time)
EP (1 time)
2018 White Paper-Geriatric Emergency Medicine Education: Current State, Challenges, and Recommendations to Enhance the Emergency Care of Older Adults.
69  global emergency medicine
(2 times)
Emergency Medicine
(2 times)
EDs (1 time)
EM (1 time)
IEMFC (1 time)
2014 Career paths and practice patterns of global emergency medicinephysicians: a cross-sectional survey.
70  Global Entrepreneurship Monitor
(2 times)
Cognitive Science
(1 time)
--- 2017 A Lifespan Perspective on Entrepreneurship: Perceived Opportunities and Skills Explain the Negative Association between Age and Entrepreneurial Activity.
71  glucose-electrolyte mixture
(2 times)
Gastroenterology
(2 times)
--- 1984 Comparison of two feeding regimens following acute gastroenteritis in infancy.
72  glycolipid- and cholesterol-enriched membrane
(2 times)
Biochemistry
(2 times)
--- 1999 Incorporation of MAL, an integral protein element of the machinery for the glycolipid and cholesterol-mediated apical pathway of transport, into artificial membranes requires neither of these lipid species.
73  granulin/epithelin module
(2 times)
Biochemistry
(2 times)
--- 2008 Structure dissection of human progranulin identifies well-folded granulin/epithelin modules with unique functional activities.
74  grief evaluation measure
(2 times)
Health Services
(1 time)
--- 2005 The grief evaluation measure (GEM): an initial validation study.
75  Grupo Espanol de Mieloma
(2 times)
Neoplasms
(2 times)
MM (2 times)
CR (1 time)
MM-PCs (1 time)
2012 Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients.
76  guanine-nucleotide exchange modulator
(2 times)
Natural Science Disciplines
(1 time)
CTCs (1 time)
FZD (1 time)
GPCRs (1 time)
2018 Prognostic Relevance of CCDC88C (Daple) Transcripts in the Peripheral Blood of Patients with Cutaneous Melanoma.
77  opportunities--Graduate Entry Medicine
(2 times)
Medicine
(2 times)
--- 2011 Challenges & opportunities--Graduate Entry Medicine (GEM).
78  cancer-gemcitabine
(1 time)
General Surgery
(1 time)
PARP (1 time)
2007 Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells.
79  copolymer-gemcitabine
(1 time)
Molecular Biology
(1 time)
HPMA (1 time)
i.p (1 time)
RAFT (1 time)
2017 Backbone Degradable N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates with Gemcitabine and Paclitaxel: Impact of Molecular Weight on Activity toward Human Ovarian Carcinoma Xenografts.
80  Ga-East Municipality
(1 time)
Medicine
(1 time)
--- 2017 Factors influencing use of analgesics among construction workers in the Ga-Eastmunicipality of the Greater Accra region, Ghana.
81  galvanic eye movement
(1 time)
Otolaryngology
(1 time)
CGT (1 time)
GBS (1 time)
1991 Compensatory process of vestibular neuronitis. From findings of combined galvanic test and caloric test.
82  Gambling Experience Measure
(1 time)
Psychiatry
(1 time)
--- 2006 Psychological experience of gambling and subtypes of pathological gamblers.
83  gas exchange measurement
(1 time)
Nutritional Sciences
(1 time)
DIT (1 time)
2014 Comparison of the GEM and the ECAL indirect calorimeters against the Deltatrac for measures of RMR and diet-induced thermogenesis.
84  Gas exchange monitoring
(1 time)
Anesthesiology
(1 time)
--- 1992 [Validation of the gas exchange monitoring function of the Engstrom Elvira respirator].
85  gas expansion molding
(1 time)
Biomedical Engineering
(1 time)
AM (1 time)
CSCs (1 time)
ELDA (1 time)
2011 Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line.
86  gaseous effluent monitor
(1 time)
Environmental Health
(1 time)
--- 2018 Monte Carlo simulation of the responses of gaseous effluent monitors to radioactive isotopes.
87  Gaseous Electron Multiplier
(1 time)
Biomedical Engineering
(1 time)
AUG (1 time)
2016 Gaseous electron multiplier-based soft x-ray plasma diagnostics development: Preliminary tests at ASDEX Upgrade.
88  Gaussian effort model
(1 time)
Medical Informatics
(1 time)
--- 2020 Patient asynchrony modelling during controlled mechanical ventilation therapy.
89  Gaussian elimination method
(1 time)
Radiotherapy
(1 time)
AB-IMRT (1 time)
CI (1 time)
FSA (1 time)
2011 A hybrid algorithm for instant optimization of beam weights in anatomy-based intensity modulated radiotherapy: A performance evaluation study.
90  Gaussian Evolutionary Method
(1 time)
Biochemistry
(1 time)
--- 2002 GEM: a Gaussian Evolutionary Method for predicting protein side-chain conformations.
91  GCR exposure marker
(1 time)
Genetics
(1 time)
GCPR (1 time)
GCR (1 time)
GSM (1 time)
2018 Quantitative Proteomic Analysis of the Hippocampus of Rats with GCR-Induced Spatial Memory Impairment.
92  gelatin encapsulated microbubbles
(1 time)
Radiology
(1 time)
--- 1982 Ultrasonic contrast enhancement of tissue by encapsulated microbubbles.
93  GEM +nab-PTX
(1 time)
Cell Biology
(1 time)
nab (1 time)
PDOX (1 time)
2018 Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.
94  GEM +S. typhimurium A1-R
(1 time)
Cell Biology
(1 time)
nab (1 time)
PDOX (1 time)
2018 Tumor targeting Salmonella typhimurium A1-R in combination with gemcitabine (GEM) regresses partially GEM-resistant pancreatic cancer patient-derived orthotopic xenograft (PDOX) nude mouse models.
95  Gem GTPase
(1 time)
Veterinary Medicine
(1 time)
AM (1 time)
CALB1 (1 time)
KU (1 time)
2003 Analyses of beta-1 syntrophin, syndecan 2 and gem GTPase as candidates for chicken muscular dystrophy.
96  GEM+rMETase
(1 time)
Cell Biology
(1 time)
PDOX (1 time)
rMETase (1 time)
2018 Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.
97  Gem-associated protein 2-like isoform X1
(1 time)
Chemistry
(1 time)
bp (1 time)
dsRNA (1 time)
Mn-IAG (1 time)
2019 Potential Functions of Gem-Associated Protein 2-Like Isoform X1 in the Oriental River Prawn Macrobrachium nipponense: Cloning, qPCR, In Situ Hybridization, and RNAi Analysis.
98  gemcitabine (GEM)/ docetaxel (DOC)
(1 time)
Cell Biology
(1 time)
iPDOX (2 times)
CPA (1 time)
DOC (1 time)
2017 Combination of gemcitabine and docetaxel regresses both gastric leiomyosarcoma proliferation and invasion in an imageable patient-derived orthotopic xenograft (iPDOX) model.
99  Gemcitabine 2',2'-difluoro 2'-deoxy cytosine
(1 time)
Chemistry
(1 time)
Cyt (1 time)
1996 Ab initio quantum mechanical and X-ray crystallographic studies of gemcitabine and 2'-deoxy cytosine.
100  gemcitabine treatment
(1 time)
Neoplasms
(1 time)
AHCC (1 time)
CRP (1 time)
mGPS (1 time)
2016 Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.